Epoetin alfa: future directions and future research.
Ludwig
Heinz
H
Department of Medicine and Medical Oncology, Wilhelminenspital, Montleartstrasse 37, A-1171 Vienna, Austria. Heinz.Ludwig@weinkav.at
Hudis
Clifford A
CA
Goss
Glen
G
Leyland-Jones
Brian
B
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D000818:Animals; D015687:Cell Hypoxia; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000494:pharmacology / Q000627:therapeutic use*; D006397:Hematinics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications; D011788:Quality of Life; D011994:Recombinant Proteins
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa